Psychopharmacology
by Santek, Michelle
1. 1980-1984
1.1. Neuropharmacological research extended from neurochemistry at synaptic cleft to receptor bindings
1.2. Clinical methodology remained restricted to demonstrating therapeutic efficacy
1.3. * The gap grew so wide that it required the translation of findings that
1.4. their clinical relevance could be understood
2. 1970-1978
2.1. Psychotropic drugs became primary form of treatment
3. 1966-1968
3.1. PHARMACOLOGICAL HETEROGENEITY WITHIN DIAGNOSES
3.1.1. Precluded the generation of information about pathophysiology of mental disorders
3.1.2. Delayed acceptance of psychotropic drugs for clinical use
4. 1935
4.1. -Benzedrine. Dr. Charles bradley realized that performance in creased in childen
5. 1956
5.1. Fritz Freyhan Pharmacological re-evaluation of psychiatric nosology needed
5.1.1. Fritz Freyhan 1956 Pharmacological re-evaluation of psychiatric nosology needed
6. 1948
6.1. Lithium
7. 1955
7.1. Ritalin approved
8. 1957
8.1. anitdpepressannts
8.2. Collegium Internationale Neuro-Psychopharmacologicum (CINP)
8.2.1. 1990's
8.2.1.1. 1990s, the college extended its activities by organizing other meetings, including president’s workshops, regional meetings, educational seminars and other programs
8.2.2. 29th centry
8.2.2.1. end of the 20th century CINP was a legal entity that was registered in Switzerland with domicile in Zurich.
8.2.3. 21st cenrty
8.2.3.1. early years of the 21st century CINP established a central office and a congress-organizing group.